NCT02691078View on ClinicalTrials.gov

Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 10, 2018

Conditions
Neuroendocrine Tumors
Interventions
OTHER

99m Tc - HYNIC -TOC EDDA and 111In - DTPA-octreotide

The patient will undercome an PET/CT exam with 99m Tc - HYNIC -TOC EDDA, after 20 days of wash out, the same patient will undercome the same exam with 111In - DTPA-octreotide in order to compare both radiopharmaceuticals

Trial Locations (1)

Unknown

Instituto do Cérebro do Rio Grande do Sul, Porto Alegre

All Listed Sponsors
collaborator

Financiadora de Estudos e Projetos

OTHER

collaborator

Instituto do Cérebro do Rio Grande do Sul - InsCer

UNKNOWN

lead

Latin American Cooperative Oncology Group

OTHER

NCT02691078 - Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors | Biotech Hunter | Biotech Hunter